Literature DB >> 20150806

Humanized mouse models to study human diseases.

Michael A Brehm1, Leonard D Shultz, Dale L Greiner.   

Abstract

PURPOSE OF REVIEW: Update on humanized mouse models and their use in biomedical research. RECENT
FINDINGS: The recent description of immunodeficient mice bearing a mutated IL-2 receptor gamma chain (IL2rgamma) facilitated greatly the engraftment and function of human hematolymphoid cells and other cells and tissues. These mice permit the development of human immune systems, including functional T and B cells, following engraftment of hematopoietic stem cells (HSCs). The engrafted functional human immune systems are capable of T and B cell-dependent immune responses, antibody production, antiviral responses, and allograft rejection. Immunodeficient IL2rgamma(null) mice also support heightened engraftment of primary human cancers and malignant progenitor cells, permitting in-vivo investigation of pathogenesis and function. In addition, human-specific infectious agents for which animal models were previously unavailable can now be studied in vivo using these new-generation humanized mice.
SUMMARY: Immunodeficient mice bearing an IL2rgamma(null) mutated gene can be engrafted with functional human cells and tissues, including human immune systems, following engraftment with human hematolymphoid cells. These mice are now used as in-vivo models to study human hematopoiesis, immunity, regeneration, stem cell function, cancer, and human-specific infectious agents without putting patients at risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150806      PMCID: PMC2892284          DOI: 10.1097/MED.0b013e328337282f

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  67 in total

Review 1.  Novel humanized murine models for HIV research.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

2.  Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.

Authors:  O ter Brake; N Legrand; K J von Eije; M Centlivre; H Spits; K Weijer; B Blom; B Berkhout
Journal:  Gene Ther       Date:  2008-07-31       Impact factor: 5.250

3.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).

Authors:  Yohei Watanabe; Takeshi Takahashi; Akira Okajima; Miho Shiokawa; Naoto Ishii; Ikumi Katano; Ryoji Ito; Mamoru Ito; Masayoshi Minegishi; Naoko Minegishi; Shigeru Tsuchiya; Kazuo Sugamura
Journal:  Int Immunol       Date:  2009-06-10       Impact factor: 4.823

4.  Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.

Authors:  Beatriz M Carreno; Joel R Garbow; Grant R Kolar; Erin N Jackson; John A Engelbach; Michelle Becker-Hapak; Leonidas N Carayannopoulos; David Piwnica-Worms; Gerald P Linette
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

5.  Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.

Authors:  Asahi Ito; Takashi Ishida; Hiroki Yano; Atsushi Inagaki; Susumu Suzuki; Fumihiko Sato; Hisashi Takino; Fumiko Mori; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida; Hiroshi Inagaki; Ryuzo Ueda
Journal:  Cancer Immunol Immunother       Date:  2008-12-02       Impact factor: 6.968

Review 6.  Humanized mice for modeling human infectious disease: challenges, progress, and outlook.

Authors:  Nicolas Legrand; Alexander Ploss; Rudi Balling; Pablo D Becker; Chiara Borsotti; Nicolas Brezillon; Jennifer Debarry; Ype de Jong; Hongkui Deng; James P Di Santo; Stephanie Eisenbarth; Elizabeth Eynon; Richard A Flavell; Carlos A Guzman; Nicholas D Huntington; Dina Kremsdorf; Michael P Manns; Markus G Manz; Jean-Jacques Mention; Michael Ott; Chozhavendan Rathinam; Charles M Rice; Anthony Rongvaux; Sean Stevens; Hergen Spits; Hélène Strick-Marchand; Hitoshi Takizawa; Anja U van Lent; Chengyan Wang; Kees Weijer; Tim Willinger; Patrick Ziegler
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

7.  Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand.

Authors:  Osnat Bohana-Kashtan; Sebastien Morisot; Richard Hildreth; Cory Brayton; Hyam I Levitsky; Curt I Civin
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

8.  Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.

Authors:  Diana M Brainard; Edward Seung; Nicole Frahm; Annaiah Cariappa; Charles C Bailey; William K Hart; Hae-Sook Shin; Sarah F Brooks; Heather L Knight; Quentin Eichbaum; Yong-Guang Yang; Megan Sykes; Bruce D Walker; Gordon J Freeman; Shiv Pillai; Susan V Westmoreland; Christian Brander; Andrew D Luster; Andrew M Tager
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

9.  Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.

Authors:  Till Strowig; Cagan Gurer; Alexander Ploss; Yi-Fang Liu; Frida Arrey; Junji Sashihara; Gloria Koo; Charles M Rice; James W Young; Amy Chadburn; Jeffrey I Cohen; Christian Münz
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

10.  IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.

Authors:  Nicholas D Huntington; Nicolas Legrand; Nuno L Alves; Barbara Jaron; Kees Weijer; Ariane Plet; Erwan Corcuff; Erwan Mortier; Yannick Jacques; Hergen Spits; James P Di Santo
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

View more
  80 in total

1.  Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever.

Authors:  Raja Vuyyuru; Hongqi Liu; Tim Manser; Kishore R Alugupalli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Trends Microbiol       Date:  2012-04-12       Impact factor: 17.079

Review 3.  From hacking the human genome to editing organs.

Authors:  Takamasa Tobita; Jorge Guzman-Lepe; Alexandra Collin de l'Hortet
Journal:  Organogenesis       Date:  2015-11-20       Impact factor: 2.500

Review 4.  Insulin as a key autoantigen in the development of type 1 diabetes.

Authors:  Maki Nakayama
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

Review 5.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

6.  Irradiated compared with nonirradiated NSG mice for the development of a human B-cell lymphoma model.

Authors:  Deepti Chadalavada; Trinka W Adamson; John C Burnett; Robert W Chen; John J Rossi
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

7.  Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development.

Authors:  Ken-Edwin Aryee; Leonard D Shultz; Michael A Brehm
Journal:  Methods Mol Biol       Date:  2014

Review 8.  Using stem cells to study and possibly treat type 1 diabetes.

Authors:  D A Melton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

9.  OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.

Authors:  Mark Wunderlich; Ryan A Brooks; Rushi Panchal; Garrett W Rhyasen; Gwenn Danet-Desnoyers; James C Mulloy
Journal:  Blood       Date:  2014-04-28       Impact factor: 22.113

10.  Engineering the human thymic microenvironment to support thymopoiesis in vivo.

Authors:  Brile Chung; Amélie Montel-Hagen; Shundi Ge; Garrett Blumberg; Kenneth Kim; Sam Klein; Yuhua Zhu; Chintan Parekh; Arumugam Balamurugan; Otto O Yang; Gay M Crooks
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.